Join the Class Action Suit Against Reckitt Benckiser Group plc
Important Announcement for Shareholders of Reckitt Benckiser Group plc
The Gross Law Firm has issued a vital notification to shareholders of Reckitt Benckiser Group plc (OTCQX: RBGLY), urging those who bought shares during a specified class period to take action.
Understanding the Class Period and Their Rights
Shareholders who purchased shares of RBGLY from January 13, 2021, to July 28, 2024, are encouraged to reach out to the firm. It is important to note that being appointed as a lead plaintiff is not necessary to join in any recovery from this case.
Registering for the Class Action
Individuals interested in pursuing claims against Reckitt should not hesitate to get involved. The registration is essential for those wishing to participate, and the Gross Law Firm is available to assist with the process.
Details of the Allegations
The allegations within the complaint highlight serious concerns regarding Reckitt's cow's milk-based formula, Enfamil. It states that preterm infants were at greater risk of developing necrotizing enterocolitis (NEC) when using this product. The firm contends that Reckitt failed to disclose this vital information, which may have significantly affected their sales and led to numerous legal claims.
Deadline for Shareholders
Shareholders are reminded that the deadline for registering for this class action is August 4, 2025. Delaying could prevent individuals from asserting their rights. Interested parties should act promptly and provide their information to ensure they are included in the proceedings.
Next Steps for Interested Shareholders
Once registered as a shareholder who purchased shares of RBGLY during the designated timeframe, individuals will gain access to a portfolio monitoring software. This will keep them updated on the status of the case, ensuring they remain informed throughout the process.
The Role of The Gross Law Firm
The Gross Law Firm stands out as a recognized national leader in class action law. Their dedication revolves around safeguarding the rights of investors affected by deceit and illegitimate business practices. They are committed to promoting good corporate citizenship and accountability among companies.
Contact Information
If you have questions or wish to participate, the firm can be reached at:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Phone: (646) 453-8903
Frequently Asked Questions
What is the purpose of this class action suit?
The class action is aimed at holding Reckitt Benckiser accountable for allegedly misleading shareholders regarding the safety of their product Enfamil.
When is the deadline to join the class action?
The deadline to register for the class action is August 4, 2025.
Do I need to be a lead plaintiff to participate?
No, being a lead plaintiff is not required to partake in any recovery.
How will I be informed about the case updates?
Once registered, you will have access to a portfolio monitoring system that provides status updates regarding the case.
Why should I choose Gross Law Firm?
Gross Law Firm specializes in class action cases and is committed to advocating for the rights of investors who have been harmed by corporate misconduct.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.